Medkart Welcomes Government’s 30% Margin Cap on 137 Cancer Medicines, Urges Patients to Check Revised Prices
With the government set to cap trade margins on 137 anti-cancer medicines from November 9, Medkart, one of India’s largest generic-first pharmacy chains, has welcomed the move as a significant step towards making cancer care more affordable, and is urging patients and caregivers…